These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 35837382)

  • 1. Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
    Chepy A; Bourel L; Koether V; Launay D; Dubucquoi S; Sobanski V
    Front Immunol; 2022; 13():930970. PubMed ID: 35837382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoantibodies and their clinical characteristics in systemic sclerosis].
    Hamaguchi Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
    Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
    Miyake M; Matsushita T; Takehara K; Hamaguchi Y
    Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
    Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
    Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Hamaguchi Y; Hasegawa M; Fujimoto M; Matsushita T; Komura K; Kaji K; Kondo M; Nishijima C; Hayakawa I; Ogawa F; Kuwana M; Takehara K; Sato S
    Br J Dermatol; 2008 Mar; 158(3):487-95. PubMed ID: 18205876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma autoantibodies in guiding monitoring and treatment decisions.
    Shah S; Denton CP
    Curr Opin Rheumatol; 2022 Nov; 34(6):302-310. PubMed ID: 36082759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibody-negative systemic sclerosis.
    Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
    Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting.
    Kuwana M
    J Nippon Med Sch; 2017; 84(2):56-63. PubMed ID: 28502960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China.
    Hui M; Wang X; Zhou J; Zhang L; Duan X; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
    Z Rheumatol; 2024 Feb; 83(Suppl 1):160-166. PubMed ID: 35852599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear Antibodies in Systemic Sclerosis: an Update.
    Stochmal A; Czuwara J; Trojanowska M; Rudnicka L
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):40-51. PubMed ID: 30607749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis.
    Clark KEN; Campochiaro C; Csomor E; Taylor A; Nevin K; Galwey N; Morse MA; Singh J; Teo YV; Ong VH; Derrett-Smith E; Wisniacki N; Flint SM; Denton CP
    Ann Rheum Dis; 2021 Dec; 80(12):1584-1593. PubMed ID: 34230031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis in mother and daughter with susceptible HLA haplotype and anti-topoisomerase I autoantibodies.
    Kurteva EK; Boyadzhieva VV; Stoilov NR
    Rheumatol Int; 2020 Jun; 40(6):1001-1009. PubMed ID: 31970496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis.
    Shanmugam VK; Swistowski DR; Saddic N; Wang H; Steen VD
    Clin Rheumatol; 2011 Oct; 30(10):1363-8. PubMed ID: 21614475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
    Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
    J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.